In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Biota FLUNET(tm) alliance with Sankyo
Biota and Aerogen Sign Flu Development Agreement
Biota awarded US Government funding for new influenza drug
Biota awarded US Government funding for new influenza drug
Biota sues GSK for failure to support its influenza drug RelenzaTM
Gentris and Sankyo Pharma establish partnership
Sankyo gains rights to cholesterol lowering agent
Sankyo and Fujisawa Agree to Discontinue Business Arrangements on Sankyo's Antifungal CS-758